Abstract: The present invention provides a scalable process for the preparation of stilbenes by (i) condensing 3,5-dialkylbenzyl phosphonates with 4?-O-tetrahydropyranyl benzaldehyde to get 3,5-alkyl-4?-O-tetrahydropyranyl Stilbene and (ii) deprotecting the obtained 3,5-Dialkyl-4?-O-tetrahydropyranylstilbene to yield stilbenes. The present invention also provides a novel intermediate 3,5-Dialkyl-4?-O-tetrahydropyranyl stilbene, which is a key intermediate for the synthesis of stilbenes such as Pterostilbene and Resveratrol. The present invention also provides characteristics of various solid forms of Pterostilbene, methods for their preparation, as well as dosage forms containing the same for administration to or consumption by humans.

Abstract: The invention relates to a method for coating metallic surfaces with an aqueous composition as a solution or as a dispersion, wherein the composition contains a) at least one phosphate, b) at least 0.1 g/L of at least one titanium and/or zirconium compound, c) at least one complexing agent, d) cations of aluminum, chromium(III), and/or zinc and/or at least one compound containing aluminum, chromium(III), and/or zinc, and e) 1 to 500 g/L of at least one acid-tolerant cationic or nonionic organic polymer/copolymer, relative to the content of the solids and active substances in these additives.

Abstract: A box-shaped electric control cabinet is provided which can be closed by a cover and which is used to receive electric components and devices for a blade angle adjustment drive (pitch drive) of a wind energy power plant, by means of which one or more rotor blades of the plant can be rotated about the blade axis. The control cabinet includes at least two cabinet segments, and specific electric components and devices are associated with respectively each module according to its function. The cabinet segments can be associated with and/or assigned to respectively different electric components and devices, with which, combined as a part function, different total functions and/or embodiment forms of the control cabinet can be produced or are producible.

Abstract: Crystalline salts of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine, compositions thereof, methods for their preparation, and methods for their use are disclosed.

Abstract: Methods of making polymorphs of the benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile.

Abstract: The invention provides and describes solid state 17?-ethynyl-androst-5-ene-3?,7?,17?-triol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17?-ethynyl-androst-5-ene-3?,7?,17?-triol include Form I anhydrate and Form IV and Form V solvates. The invention further relates to solid and suspension formulations containing 17?-ethynyl-androst-5-ene-3?,7?,17?-triol in a described solid state form and use of the formulations to treat hyperglycemic conditions, such as type 2 diabetes and metabolic syndrome, and autoimmune conditions, such as rheumatoid arthritis, ulcerative colitis and type 1 diabetes, among other inflammation related conditions in subjects or human patients. The invention also relates to methods to make liquid formulations from solid state forms of 17?-ethynyl-androst-5-ene-3?,7?,17?-triol and uses of such formulations in treating the described conditions.

Abstract: The invention provides and describes solid state 17?-ethynyl-androst-5-ene-3?,7?,17?-triol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17?-ethynyl-androst-5-ene-3?,7?,17?-triol include Form I anhydrate and Form IV and Form V solvates. The invention further relates to solid and suspension formulations containing 17?-ethynyl-androst-5-ene-3?,7?,17?-triol in a described solid state form and use of the formulations to treat hyperglycemic conditions, such as type 2 diabetes and metabolic syndrome, and autoimmune conditions, such as rheumatoid arthritis, ulcerative colitis and type 1 diabetes, among other inflammation related conditions in subjects or human patients. The invention also relates to methods to make liquid formulations from solid state forms of 17?-ethynyl-androst-5-ene-3?,7?,17?-triol and uses of such formulations in treating the described conditions.

Abstract: In at least one embodiment, an ambient lighting system comprising a lighting module and a controller is provided. The lighting module is configured to drive a light emitting device (LED) arrangement to display a desired ambient color in response to a lighting control signal and to transmit a lighting status signal providing diagnostic information for one of the lighting module and the LED arrangement. The controller is configured to transmit the lighting control signal including first digital data indicative of the desired ambient color and a feed signal for powering the lighting module on a bi-directional data communication bus between the controller and the lighting module. The controller is further configured to receive the lighting status signal on the bi-directional data communication bus.

Abstract: The invention provides and describes solid state 17?-ethynyl-androst-5-ene-3?, 7?,17?-triol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17?-ethynyl-androst-5-ene-3?, ?,17?-triol include Form I anhydrate and Form IV and Form V solvates. The invention further relates to solid and suspension formulations containing 17?-ethynyl-androst-5-ene-3?,7?,17?-triol in a described solid state form and use of the formulations to treat hyperglycemic conditions, such as type 2 diabetes and metabolic syndrome, and autoimmune conditions, such as rheumatoid arthritis, ulcerative colitis and type 1 diabetes, among other inflammation related conditions in subjects or human patients. The invention also relates to methods to make liquid formulations from solid state forms of 17?-ethynyl-androst-5-ene-3?, 7?,17?-triol and uses of such formulations in treating the described conditions.

Abstract: A steam turbine has a two-shell housing, including an outer casing and an inner casing arranged therein, as well as a pipe that extends through the outer casing for supplying and/or removing steam to or from the inner casing, the pipe being provided with a pair of apertures arranged opposite each other on the inner casing. According to the invention, a first steam supply or discharge pipe can be connected to a first aperture, and the second aperture is closed by a cover.

Abstract: Crystalline salts of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine, compositions thereof, methods for their preparation, and methods for their use are disclosed.

Abstract: The present invention provides a scalable process for the preparation of stilbenes by (i) condensing 3,5-dialkylbenzyl phosphonates with 4?-O-tetrahydropyranyl benzaldehyde to get 3,5-alkyl-4?-O-tetrahydropyranyl Stilbene and (ii) deprotecting the obtained 3,5-Dialkyl-4?-O-tetrahydropyranylstilbene to yield stilbenes. The present invention also provides a novel intermediate 3,5-Dialkyl-4?-O-tetrahydropyranyl stilbene, which is a key intermediate for the synthesis of stilbenes such as Pterostilbene and Resveratrol. The present invention also provides characteristics of various solid forms of Pterostilbene, methods for their preparation, as well as dosage forms containing the same for administration to or consumption by humans.

Abstract: Apparatus and methods for network protection monitor the functional state of a control component on a circuit protection device and provide a back up control signal to activate the circuit protection device to protect the network in the event that the control component on the circuit protection device stops functioning.

Abstract: The invention relates to a process for coating metal surfaces with an aqueous composition in the form of a solution or in the form of a dispersion, the composition comprising at least one phosphate, at least 3 g/l of at least one titanium or/and zirconium compound and at least one complexing agent, and also to corresponding aqueous compositions.

Abstract: An ambient lighting system in a vehicle is provided. The system comprises a lighting module and a central controller. The lighting module is configured for electrical connection to the vehicle and for driving at least one light emitting diode (LED) arrangement to display a desired ambient color and intensity. The central controller is configured to transmit a roll call command on a data communication bus to the lighting module to determine whether the lighting module is electrically connected to the vehicle.

Abstract: A steam turbine having an exhaust-steam casing for directing an exhaust-steam mass flow, a shaft bearing for mounting a turbine shaft, and at least two bearing struts, by means of which the shaft bearing is fastened to the exhaust-steam casing, is characterized according to the invention in that each of the at least two bearing struts has a cooling cavity arranged in the respective bearing strut for directing a coolant, and the cooling cavities of the at least two bearing struts are connected in a fluidically conductive manner via a closed-off connecting cavity in the region of the shaft bearing.

Abstract: A balun, generally including a substrate, a microstrip conductor, and a parallel strip conductor is described, where a characteristic impedance of the balun is substantially constant at each cross-sectional point along a length of the balun. A transverse electromagnetic horn antenna can transmit and receive ultra-wide band pulses, and includes a first metal conductor and a second metal conductor, where a characteristic impedance of the first and second conductor varies over a length of the antenna in a controlled means.

Abstract: Compositions comprising Compound I, wherein the Compound I is present in one or more polymorphic forms. Also provided are kits and articles of manufacture with compositions comprising one or more polymorphs of Compound I, and methods of using the compositions to treat various diseases.

Abstract: The invention provides and describes solid state 17?-ethynyl-androst-5-ene-3?,7?,17?-triol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17?-ethynyl-androst-5-ene-3?,7?,17?-triol include Form I anhydrate and Form IV and Form V solvates. The invention further relates to solid and suspension formulations containing 17?-ethynyl-androst-5-ene-3?,7?,17?-triol in a described solid state form and use of the formulations to treat hyperglycemic conditions, such as type 2 diabetes and metabolic syndrome, and autoimmune conditions, such as rheumatoid arthritis, ulcerative colitis and type 1 diabetes, among other inflammation related conditions in subjects or human patients. The invention also relates to methods to make liquid formulations from solid state forms of 17?-ethynyl-androst-5-ene-3?,7?,17?-triol and uses of such formulations in treating the described conditions.

Abstract: In at least one embodiment, an ambient lighting system comprising a lighting module and a controller is provided. The lighting module is configured to drive a light emitting device (LED) arrangement to display a desired ambient color in response to a lighting control signal and to transmit a lighting status signal providing diagnostic information for one of the lighting module and the LED arrangement. The controller is configured to transmit the lighting control signal including first digital data indicative of the desired ambient color and a feed signal for powering the lighting module on a bi-directional data communication bus between the controller and the lighting module. The controller is further configured to receive the lighting status signal on the bi-directional data communication bus.